Co-Founder Helmy Eltoukhy Just Bought 4.7% More Shares In Guardant Health, Inc. (NASDAQ:GH)

Guardant Health, Inc. (NASDAQ:GH) shareholders (or potential shareholders) will be happy to see that the Co-Founder, Helmy Eltoukhy, recently bought a whopping US$10m worth of stock, at a price of US$96.15. While that only increased their holding size by 4.7%, it is still a big swing by our standards.

Check out our latest analysis for Guardant Health

The Last 12 Months Of Insider Transactions At Guardant Health

Notably, that recent purchase by Helmy Eltoukhy is the biggest insider purchase of Guardant Health shares that we've seen in the last year. So it's clear an insider wanted to buy, at around the current price, which is US$104. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. Happily, the Guardant Health insiders decided to buy shares at close to current prices.

In the last twelve months Guardant Health insiders were buying shares, but not selling. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Does Guardant Health Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Guardant Health insiders own 4.4% of the company, currently worth about US$465m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Does This Data Suggest About Guardant Health Insiders?

The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Guardant Health. That's what I like to see! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. You'd be interested to know, that we found 2 warning signs for Guardant Health and we suggest you have a look.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.